Paki, an associate in the New York office, is a member of the firm’s Intellectual Property Litigation Group. Paki focuses her practice on intellectual property law and technology. She has experience in the areas of patent litigation (including Hatch-Waxman litigation), patent prosecution, patent interferences, due diligence, counseling and opinions. Her work has primarily involved technologies in the fields of pharmaceuticals, biotechnology and medical devices.
Paki’s doctorate thesis was on the structural and biochemical characterization of the regulatory subunit of protein kinase A. She has published several articles on structural and biochemical analysis of protein kinase A. Additionally, she was the recipient of the Life Sciences Research Foundation Award for structural studies of the HIV capsid protein as a post-doctoral fellow.
- Represented branded drug manufacturers in various phases of ANDA infringement litigations.
- Represented a client in patent interference against a pharmaceutical company involving “reshaped” humanized immunoglobulins.
- Represented a biotechnology company and academic institution in a declaratory judgment action on behalf of several plaintiffs challenging the validity and constitutionality of certain gene patents.
- Successfully defended through jury trial a coronary stent manufacturer in a patent infringement damages action.
- Successfully represented a financial institution at bench trial in a trademark infringement case.
- Represented a private equity company in a joint venture with a pharmaceutical company.
- Successfully represented a tobacco company in a 2nd Circuit reversal of class certification in a nationwide RICO fraud action for the sale of “lights” cigarettes.